| Product NDC: | 65862-248 |
| Proprietary Name: | Escitalopram Oxalate |
| Non Proprietary Name: | Escitalopram Oxalate |
| Active Ingredient(s): | 5 mg/5mL & nbsp; Escitalopram Oxalate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65862-248 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079062 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120403 |
| Package NDC: | 65862-248-24 |
| Package Description: | 240 mL in 1 BOTTLE (65862-248-24) |
| NDC Code | 65862-248-24 |
| Proprietary Name | Escitalopram Oxalate |
| Package Description | 240 mL in 1 BOTTLE (65862-248-24) |
| Product NDC | 65862-248 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Escitalopram Oxalate |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20120403 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | ESCITALOPRAM OXALATE |
| Strength Number | 5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |